Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV) was the recipient of a large decline in short interest during the month of March. As of March 31st, there was short interest totalling 402,624 shares, a decline of 6.5% from the March 15th total of 430,733 shares. Based on an average daily volume of 25,344 shares, the days-to-cover ratio is currently 15.9 days.
Kitov Pharmaceuticals Holdings (NASDAQ:KTOV) opened at 1.72 on Friday. The firm’s 50 day moving average price is $1.90 and its 200 day moving average price is $2.56. The firm’s market cap is $13.18 million. Kitov Pharmaceuticals Holdings has a 52-week low of $1.51 and a 52-week high of $5.34.
An institutional investor recently raised its position in Kitov Pharmaceuticals Holdings stock. Menta Capital LLC increased its position in shares of Kitov Pharmaceuticals Holdings Ltd (NASDAQ:KTOV) by 34.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 82,619 shares of the company’s stock after buying an additional 21,138 shares during the period. Menta Capital LLC owned 1.08% of Kitov Pharmaceuticals Holdings worth $257,000 at the end of the most recent reporting period. Institutional investors own 6.54% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: “Kitov Pharmaceuticals Holdings Ltd (KTOV) Short Interest Down 6.5% in March” was originally published by Transcript Daily and is the sole property of of Transcript Daily. If you are reading this piece of content on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright law. The correct version of this piece of content can be read at https://transcriptdaily.com/2017/05/10/short-interest-in-kitov-pharmaceuticals-holdings-ltd-ktov-decreases-by-6-5-updated-updated.html.
Kitov Pharmaceuticals Holdings Company Profile
Kitov Pharmaceuticals Holdings Ltd is an Israel-based company that develops non-steroidal anti-inflammatory drugs that treat pain without raising blood pressure, thus avoiding the increased risk of heart attacks, strokes or death.
Receive News & Ratings for Kitov Pharmaceuticals Holdings Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kitov Pharmaceuticals Holdings Ltd and related companies with MarketBeat.com's FREE daily email newsletter.